UNIVERSAL HEALTH SERVICES INC — Form 8-K
Filed July 28, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 38/100
What the filing says
UHS reported Q2 2026 net income of $358.4M ($5.98/diluted share) on revenues of $4.64B, up 8.3% YoY. The company received a favorable $100M pre-tax impact from the Florida Medicaid directed payment program (for Oct 2024–Sept 2025 period) but offset by a $28M reserve increase for self-insured claims. Based on H1 2026 results, UHS revised full-year 2026 guidance downward: Adjusted EPS lowered to $22.28–$23.65 (from $22.64–$24.52), a 2.6% midpoint reduction; Adjusted EBITDA guidance lowered 1.9% midpoint to $2.61–$2.72B. The company also announced a $700M delayed draw term loan facility (July 2026) and completed $447.5M in share repurchases (2.565M shares) in H1 2026.
Why this rating
Guidance reduction and Medicaid benefit expiration uncertainty offset strong operational growth. Event is material relative to company size (~0.4–0.5% of annual revenue impact) but reflects normal business volatility rather than structural damage.
See more from July 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.